SELUTION4BTK Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 376 participants.
Also called NCT05055297
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 376 participants
- Registry
-
NCT05055297
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Austria, France, Germany, Hong Kong SAR China, Italy, Netherlands, New Zealand, Singapore, Switzerland
- Registry status
- Recruiting
Technical summary
Registry record NCT05055297. Randomized; single masking; primary purpose treatment. Start 2022-05-19 (actual); primary completion 2027-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SELUTION4BTK Trial
- Condition
- Peripheral Arterial Disease
- Condition
- Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
- Intervention (Device)
- SELUTION SLR™ DEB 014
- Intervention (Device)
- Plain (Uncoated) Balloon Angioplasty (PTA)
- Lead sponsor
- M.A. Med Alliance S.A.
- Collaborator
- NAMSA
- Collaborator
- Cordis US Corp.
Record details
- Record id
cardio:ct-nct05055297- Content hash
7635adf70472934fabf8c7f50ee5ce90cc63fd740cee979ef733e41a7a58316d